IA
DICE

IFP Advisors’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

IFP Advisors’s Portfolio DICE Stock Details DICE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-325
Closed -$12K – 4896
2022
Q3 		$12K Hold
325
– – ﹤0.01% 3536
2022
Q2 		$12K Hold
325
– – ﹤0.01% 3286
2022
Q1 		$12K Hold
325
– – ﹤0.01% 3286
2021
Q4 		$8K Buy
+325
New +$9.53K ﹤0.01% 2326

Other funds holding DICE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

IFP Advisors's DICE Position: Q4 2022 in Review

IFP Advisors sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q4 2022, closing a stake of 325 shares — an estimated $12K sold.

IFP Advisors first reported a position in DICE in Q4 2021 and held it in 4 quarters. The position peaked at $12K in Q3 2022. 109 funds tracked by Wall St. Rank hold DICE as of Q4 2022.

  • IFP Advisors reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • IFP Advisors sold 325 DICE Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $12K.
  • IFP Advisors first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
  • IFP Advisors's DICE Therapeutics, Inc. Common Stock position peaked at $12K in Q3 2022.
  • 109 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q4 2022.

Based on IFP Advisors's 13F filing for Q4 2022, filed 7 Feb 2023.